NeuroPace (NPCE) Interest & Investment Income (2021 - 2026)
NeuroPace (NPCE) posted Interest & Investment Income of $523000.0 for Q2 2026, down 7.43% on a QoQ basis from $565000.0 in Q1 2026, and down 27.16% year-over-year from $718000.0 in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) Interest & Investment Income (2021 - 2026) Analysis & Trends
NeuroPace has reported Interest & Investment Income for 6 years, with the latest figure at $523000.0 in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 27.16% year-over-year to $523000.0 in Q2 2026; TTM through Jun 2026 was $2.4 million, a 18.77% decrease from a year earlier, with the FY2025 full-year figure at $2.8 million, down 6.88% from the prior year.
- Interest & Investment Income was $523000.0 for Q2 2026 at NeuroPace, down from $565000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $827000.0 in Q1 2024, with the low at $134000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $642000.0, with a median of $722000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Interest & Investment Income surged 441.79% in 2023, then slipped 28.75% in 2026.
- Over 5 years, Interest & Investment Income stood at $800000.0 in 2022, then gained by 2.75% to $822000.0 in 2023, then decreased by 17.15% to $681000.0 in 2024, then decreased by 6.31% to $638000.0 in 2025, then decreased by 18.03% to $523000.0 in 2026.
- The last three Interest & Investment Income figures came in at $523000.0 (Q2 2026), $565000.0 (Q1 2026), and $638000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | 523,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 523,000.00 |
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 718,000.00 |
| Mar 31, 2025 | 793,000.00 |
| Dec 31, 2024 | 681,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 762,000.00 |
| Mar 31, 2024 | 827,000.00 |
| Dec 31, 2023 | 822,000.00 |
| Sep 30, 2023 | 769,000.00 |
| Jun 30, 2023 | 733,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 423,000.00 |
| Jun 30, 2022 | 221,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 136,000.00 |